Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 11 studies | 30% ± 8% | |
adipocyte | 4 studies | 18% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 21% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 99% | 3952.54 | 243 / 245 | 100% | 79.02 | 502 / 502 |
esophagus | 100% | 3248.05 | 1445 / 1445 | 99% | 46.10 | 181 / 183 |
liver | 100% | 6509.77 | 226 / 226 | 98% | 96.96 | 396 / 406 |
kidney | 100% | 2398.08 | 89 / 89 | 95% | 51.05 | 858 / 901 |
lung | 100% | 2341.51 | 576 / 578 | 95% | 47.76 | 1103 / 1155 |
breast | 100% | 4900.51 | 459 / 459 | 95% | 51.89 | 1062 / 1118 |
bladder | 100% | 4619.05 | 21 / 21 | 94% | 44.87 | 475 / 504 |
pancreas | 96% | 1167.61 | 315 / 328 | 98% | 52.85 | 174 / 178 |
stomach | 99% | 2262.40 | 357 / 359 | 94% | 41.96 | 268 / 286 |
uterus | 99% | 3412.53 | 168 / 170 | 93% | 46.93 | 425 / 459 |
intestine | 95% | 2995.62 | 919 / 966 | 95% | 43.80 | 501 / 527 |
thymus | 99% | 1566.29 | 645 / 653 | 86% | 29.10 | 521 / 605 |
ovary | 91% | 1198.99 | 163 / 180 | 91% | 36.52 | 393 / 430 |
brain | 100% | 3552.25 | 2635 / 2642 | 73% | 33.10 | 514 / 705 |
skin | 99% | 2112.34 | 1792 / 1809 | 61% | 23.15 | 288 / 472 |
adrenal gland | 81% | 754.19 | 209 / 258 | 64% | 25.39 | 148 / 230 |
eye | 0% | 0 | 0 / 0 | 100% | 79.65 | 80 / 80 |
ureter | 0% | 0 | 0 / 0 | 100% | 97.79 | 1 / 1 |
adipose | 100% | 5663.63 | 1203 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 31.53 | 42 / 45 |
spleen | 79% | 765.71 | 191 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 49% | 535.11 | 649 / 1335 | 0% | 0 | 0 / 0 |
heart | 36% | 300.99 | 310 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 2.34 | 4 / 29 |
peripheral blood | 3% | 28.25 | 32 / 929 | 0% | 0 | 0 / 0 |
muscle | 2% | 16.57 | 18 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008635 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c |
GO_0051480 | Biological process | regulation of cytosolic calcium ion concentration |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_1901030 | Biological process | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway |
GO_1901382 | Biological process | regulation of chorionic trophoblast cell proliferation |
GO_1904708 | Biological process | regulation of granulosa cell apoptotic process |
GO_2001244 | Biological process | positive regulation of intrinsic apoptotic signaling pathway |
GO_0006921 | Biological process | cellular component disassembly involved in execution phase of apoptosis |
GO_1901029 | Biological process | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway |
GO_0051259 | Biological process | protein complex oligomerization |
GO_0051402 | Biological process | neuron apoptotic process |
GO_1902237 | Biological process | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
GO_0010506 | Biological process | regulation of autophagy |
GO_0060546 | Biological process | negative regulation of necroptotic process |
GO_0072332 | Biological process | intrinsic apoptotic signaling pathway by p53 class mediator |
GO_0051902 | Biological process | negative regulation of mitochondrial depolarization |
GO_0097192 | Biological process | extrinsic apoptotic signaling pathway in absence of ligand |
GO_0008630 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage |
GO_1903899 | Biological process | positive regulation of PERK-mediated unfolded protein response |
GO_0001836 | Biological process | release of cytochrome c from mitochondria |
GO_0048709 | Biological process | oligodendrocyte differentiation |
GO_0008584 | Biological process | male gonad development |
GO_0006915 | Biological process | apoptotic process |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_1900119 | Biological process | positive regulation of execution phase of apoptosis |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0031901 | Cellular component | early endosome membrane |
GO_0055038 | Cellular component | recycling endosome membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005640 | Cellular component | nuclear outer membrane |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0032588 | Cellular component | trans-Golgi network membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0033106 | Cellular component | cis-Golgi network membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0051400 | Molecular function | BH domain binding |
GO_0005515 | Molecular function | protein binding |
Gene name | BOK |
Protein name | BCL-2-related ovarian killer protein isoform 6 transcript variant 16 (BCL-2-related ovarian killer protein isoform 6 transcript variant 17) (BCL-2-related ovarian killer protein isoform 6 transcript variant 18) Bcl-2-related ovarian killer protein isoform 5 BCL2-related ovarian killer, isoform CRA_a (Bcl-2-related ovarian killer protein isoform 1) Uncharacterized protein BOK Bcl-2-related ovarian killer protein isoform 7 (BCL-2-related ovarian killer protein isoform 7 transcript variant 24) (BCL2-related ovarian killer, isoform CRA_c) Bcl-2-related ovarian killer protein isoform 4 Bcl-2-related ovarian killer protein (hBOK) (Bcl-2-like protein 9) (Bcl2-L-9) Bcl-2-related ovarian killer protein isoform 3 Bcl-2 related ovarian killer |
Synonyms | hCG_33052 BCL2L9 BOKL |
Description | FUNCTION: [Isoform 1]: Apoptosis regulator that functions through different apoptotic signaling pathways . Plays a roles as pro-apoptotic protein that positively regulates intrinsic apoptotic process in a BAX- and BAK1-dependent manner or in a BAX- and BAK1-independent manner . In response to endoplasmic reticulum stress promotes mitochondrial apoptosis through downstream BAX/BAK1 activation and positive regulation of PERK-mediated unfolded protein response (By similarity). Activates apoptosis independently of heterodimerization with survival-promoting BCL2 and BCL2L1 through induction of mitochondrial outer membrane permeabilization, in a BAX- and BAK1-independent manner, in response to inhibition of ERAD-proteasome degradation system, resulting in cytochrome c release . In response to DNA damage, mediates intrinsic apoptotic process in a TP53-dependent manner . Plays a role in granulosa cell apoptosis by CASP3 activation . Plays a roles as anti-apoptotic protein during neuronal apoptotic process, by negatively regulating poly ADP-ribose polymerase-dependent cell death through regulation of neuronal calcium homeostasis and mitochondrial bioenergetics in response to NMDA excitation (By similarity). In addition to its role in apoptosis, may regulate trophoblast cell proliferation during the early stages of placental development, by acting on G1/S transition through regulation of CCNE1 expression . May also play a role as an inducer of autophagy by disrupting interaction between MCL1 and BECN1 . .; FUNCTION: [Isoform 2]: Pro-apoptotic molecule exerting its function through the mitochondrial pathway. . |
Accessions | A0A481T0M5 ENST00000318407.5 [Q9UMX3-1] Q53QM7 A0A4D6NVJ5 Q53NU8 Q9UL32 A0A4D6NU76 Q9UMX3 A0A024R4A8 A0A481T0W6 A0A481T0B6 |